|Feature||Study by Veenstra et al, 1999|
|Overall study design||Cost effectiveness analysis using a decision analytic model|
|Perspective of analysis||Healthcare payer|
|Alternatives compared||Standard or antiseptic impregnated multilumen central venous catheters|
|Effect measures||Incidence of CRBSI, death|
|Source of effectiveness data||Randomised controlled trials, meta-analysis, case control studies|
|Source of quality of life (utility) weights||N/A|
|Estimates of resource use||University of Washington Medical Center and the literature|
|Source of cost data||Direct medical costs – University of Washington Medical Center and the literature|
|Addressing uncertainty||Multivariate sensitivity analyses with varying estimates of direct medical costs, incidence of CRBSI, and death attributable to CRBSI or hypersensitivity reactionUnivariate sensitivity analyses for incremental costs: cost of CRBSI, relative risk of CRBSI, incidence of CRBSI, and additional catheter cost Univariate sensitivity analyses for incremental incidence of death: relative risk of CRBSI, incidence of CRBSI, probability of death attributable to CRBSI, and probability of hypersensitivity|
Evaluation of studies of health economics
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>
EBN Online Journal Club
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.